Showing 491-500 of 836 results for "".
Rationale #3 Tinted Serum SPF 50+
https://modernaesthetics.com/topics/skincare/rationale-3-tinted-serum-spf-50/35257/In each issue, Modern Aesthetics® magazine asks top cosmetic doctors about the newest cosmeceuticals they are offering to patients. Here, Vivian Bucay, MD, the founder and president of Bucay Center for Dermatology and Aesthetics in San Antonio, TX, discusses her history with the Rationale, an AustraRevisiting Blogs
https://modernaesthetics.com/topics/practice-development/revisiting-blogs/35253/Pro tips on blogs and blogging for aesthetic practices.Toxin Tips
https://modernaesthetics.com/topics/injectables/toxin-tips/35247/Setting reasonable expectations is essential to satisfying patients.New Products
https://modernaesthetics.com/topics/skincare/new-products-8/35242/Defenage’s 150K Hair Follicle Serum
https://modernaesthetics.com/topics/skincare/defenages-150k-hair-follicle-serum/35241/Getting Into the Holiday Spirit
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/getting-into-the-holiday-spirit/35234/‘Tis the season to be jolly, and Modern Aesthetics® magazine asked our practice management pros to weigh in on gifting options for staff, how to maximize holiday promotions, and holiday party etiquette.Trends Shaping Aesthetics in America
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/trends-shaping-aesthetics-in-america/35229/The trends plastic surgeons and dermatologists are seeing in practice.The Current State of Brazilian Butt Lifts
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/the-current-state-of-brazilian-butt-lifts/35227/Florida has become the world capital for BBLs. As mortality rates from the procedure raise concern, the Florida Board of Medicine aims to find ways to ensure safety.Women in Aesthetics: Divya Gugnani of Wander Beauty
https://modernaesthetics.com/topics/skincare/women-in-aesthetics-divya-gugnani-of-wander-beauty/35222/MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA Phase